Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised

Submitted by Anonymous (not verified) on 13 July 2026 - 15:02

Human medicines European public assessment report (EPAR): Kostaive, zapomeran, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Humalog, insulin lispro, Date of authorisation: 30/04/1996, Revision: 37, Status: Authorised

Submitted by Anonymous (not verified) on 13 July 2026 - 14:55

Human medicines European public assessment report (EPAR): Humalog, insulin lispro, Date of authorisation: 30/04/1996, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised

Submitted by Anonymous (not verified) on 13 July 2026 - 14:38

Human medicines European public assessment report (EPAR): Abasaglar (previously Abasria), insulin glargine, Date of authorisation: 09/09/2014, Revision: 14, Status: Authorised

European platform for regulatory science research meeting: June 2026 , Online, from 16 June 2026, 14:00 (CEST) to 16 June 2026, 18:00 (CEST)

Submitted by Anonymous (not verified) on 13 July 2026 - 13:19

European platform for regulatory science research meeting: June 2026 , Online, from 16 June 2026, 14:00 (CEST) to 16 June 2026, 18:00 (CEST)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness